Abstract

AbstractThe main focus of this chapter is on the 'make or buy' nature of the upstream relationships between life science and seed companies and dedicated biotechnology firms (DBFs) in Europe. The limited evidence presented in this chapter tends to suggest that so long as the agrifood biotechnology industry remains dependent on high levels of research and development expenditure and continues to draw on a diverse and unpredictably changing range of highly specialized scientific disciplines, alliances between DBFs, universities and life science companies will continue.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.